Close WindowPrint Page

News Releases 2019

The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates.

Keyword Search
 
Search by Year
DateTitle 
06/03/19Charles River Laboratories to Present at Jefferies and Goldman Sachs Investor ConferencesPrinter Friendly Version
05/16/19Charles River Laboratories Invests in Resero Analytics™Printer Friendly Version
05/07/19Charles River Laboratories Announces First-Quarter 2019 ResultsPrinter Friendly Version
04/29/19Charles River Laboratories Completes the Acquisition of CitoxlabPrinter Friendly Version
04/11/19Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference CallPrinter Friendly Version
04/09/19Charles River Laboratories and CHDI Foundation Extend Huntington’s Disease CollaborationPrinter Friendly Version
03/26/19Charles River Laboratories Highlights Commitment to Oncology Research at 2019 AACR Annual MeetingPrinter Friendly Version
03/04/19Charles River Laboratories to Present at Raymond James and Barclays Investor ConferencesPrinter Friendly Version
02/13/19Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 GuidancePrinter Friendly Version
02/13/19Charles River Laboratories Signs Binding Offer to Acquire CitoxlabPrinter Friendly Version
01/30/19Charles River Laboratories and Toxys Enter Agreement to Offer ToxTracker® in North AmericaPrinter Friendly Version
01/17/19Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference CallPrinter Friendly Version
01/16/19Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality IndexPrinter Friendly Version
01/11/19Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug DiscoveryPrinter Friendly Version
01/07/19Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version